Physician profile
Preethi Krishnan
NPI 1861611675
$7,862.56
in general payments reported to CMS, 2019-2025
42 companies · $1,179 in 2025
The $1,179 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,762 · 2020: $905 · 2021: $475 · 2022: $1,187 · 2023: $1,179 · 2024: $1,176 · 2025: $1,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,533.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $987.92 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $924.53 | 2019-2025 | |
| Abbvie INC. | $919.09 | 2020-2025 | |
| Novo Nordisk INC | $790.55 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $758.23 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Astrazeneca Pharmaceuticals LP | $661.05 | 2019-2025 | Airsupra, Farxiga |
| Allergan, INC. | $453.93 | 2019-2020 | |
| Amgen INC. | $380.99 | 2019-2025 | Evenity, Prolia, Otezla |
| Glaxosmithkline, LLC. | $233.23 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbott Laboratories | $175.63 | 2019-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $158.68 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $144.44 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.92 | 2019-2023 | Trintellix |
| Sanofi-Aventis U.S. LLC | $118.76 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $116.03 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preethi Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.